VERTEX PHARMACEUTICALS

(VRTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart VERTEX PHARMACEUTICALS
Upcoming events on VERTEX PHARMACEUTICALS
07/27/22 Interim 2022 Earnings Release (Projected)
11/02/22 Q3 2022 Earnings Release (Projected)
02/01/23 FY 2022 Earnings Release (Projected)
04/27/23 Q1 2023 Earnings Release (Projected)
Past events on VERTEX PHARMACEUTICALS
05/18/22 Annual General Meeting
05/05/22 | 04:30pm Q1 2022 Earnings Call
05/05/22 | 04:01pm Q1 2022 Earnings Release
03/08/22 | 02:50pm Cowen & Co. Health Care Conference
01/26/22 | 04:30pm FY 2021 Earnings Call
01/26/22 | 04:01pm FY 2021 Earnings Release
01/10/22 | 09:00am JP Morgan Healthcare Conference
12/01/21 | 08:30am VX-147 Phase 2 Clinical Results
11/02/21 | 03:30pm Q3 2021 Earnings Call
11/02/21 North American Cystic Fibrosis Conference - Poster No - 285
Past dividends on VERTEX PHARMACEUTICALS

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
2 489
2 431
2,4%
3 048
2 992
1,9%
4 163
3 759
11%
6 206
6 159
0,76%
7 574
7 502
0,97%
 
8 585
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
185
119
56%
1 184
1 123
5,4%
1 893
1 770
6,9%
3 601
3 649
-1,3%
4 470
4 490
-0,46%
 
4 995
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
564
538
4,9%
1 112
1 052
5,7%
1 786
1 609
11%
3 491
3 471
0,58%
4 344
4 345
-0,02%
 
4 739
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-15,7
-70,5
78%
600
771
-22%
1 395
964
45%
3 117
2 891
7,8%
2 730
2 761
-1,1%
 
4 065
 
Net income
M $
Released
Forecast
Spread
263
237
11%
2 097
740
183%
1 177
796
48%
2 712
2 608
4,0%
2 342
2 295
2,1%
 
3 253
 
EPS
$
Released
Forecast
Spread
1,04
0,90
15%
8,09
2,84
185%
4,51
3,08
46%
10,3
9,87
4,2%
9,01
8,80
2,4%
 
12,6
 
Announcement Date01/31/201802/05/201901/30/202002/01/202101/26/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread
1 724
1 657
4,1%
1 793
1 726
3,9%
1 984
1 864
6,4%
2 073
2 007
3,3%
2 098
2 074
1,1%
 
2 132
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread


 


 


 


 


 
 

 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
1 003
921
8,8%
1 029
949
8,5%
1 188
1 041
14%
1 124
1 126
-0,15%
1 167
1 188
-1,8%
 
1 191
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
821
759
8,2%
-44,3
188
-124%
1 083
844
28%
871
908
-4,1%
955
995
-4,0%
 
1 024
 
Net income
M $
Released
Forecast
Spread
653
615
6,1%
66,9
110
-39%
852
674
26%
770
720
7,0%
762
801
-4,8%
 
828
 
EPS
$
Released
Forecast
Spread
2,49
2,29
8,7%
0,26
0,69
-62%
3,28
2,51
31%
3,00
2,76
8,6%
2,96
3,14
-5,6%
 
3,13
 
Announcement Date04/29/202107/29/202111/02/202101/26/202205/05/2022-
Previous year Next Year
Upcoming sector events for VERTEX PHARMACEUTICALS
More events
Past sector events for VERTEX PHARMACEUTICALS
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise